Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Epoetin Hospira, a Proposed Biosimilar of Amgen’s Epogen by Hospira Report
Briefing Summary: US FDA Posts Advisory Committee Materials for Review of Epoetin Hospira, a Proposed Biosimilar of Amgen’s Epogen by Hospira Report